Episurf Continues to Gather Clinical Evidence During Early Commercialization Efforts

Episurf reported 3Q19 revenue of SEK 1.1MM (USD $0.1MM), +13.4% vs. 3Q18.

Gross order intake for the quarter increased 21% year over year, and 51% for the nine-month period ending September 30, 2019
Per leadership, around 80% of Episealer orders originate in Germany
Orders for the Episealer knee implant increased 60% vs. prior...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us